$0 is the total value of Tavio Capital LLC's 1 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CNC | Exit | CENTENE CORP DEL | $0 | – | -18,615 | -100.0% | -1.57% | – |
EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -34,329 | -100.0% | -3.96% | – |
PDCO | Exit | PATTERSON COS INC | $0 | – | -202,943 | -100.0% | -5.92% | – |
BAX | Exit | BAXTER INTL INC | $0 | – | -68,405 | -100.0% | -7.81% | – |
CI | Exit | CIGNA CORP NEW | $0 | – | -75,163 | -100.0% | -18.70% | – |
ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -127,819 | -100.0% | -20.22% | – |
MCK | Exit | MCKESSON CORP | $0 | – | -99,594 | -100.0% | -20.25% | – |
MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -91,479 | -100.0% | -21.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-10-01
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
ANTHEM INC | 10 | Q2 2019 | 22.5% |
BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
RETROPHIN INC | 9 | Q1 2019 | 3.4% |
ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
HUMANA INC | 8 | Q4 2019 | 37.8% |
UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-10-01 |
13F-HR | 2020-08-13 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-13 |
13F-HR | 2019-11-13 |
13F-HR | 2019-08-13 |
13F-HR | 2019-05-14 |
13F-HR | 2019-02-14 |
13F-HR | 2018-11-13 |
13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.